SCHEMBL10066225

SCHEMBL10066225

CN[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 9/20 0.61
▸ PRSS1 P07477 2/20 0.49
▸ PRSS2 P07478 2/20 0.49
▸ PRSS3 P35030 2/20 0.49
▸ TPSAB1 Q15661 2/20 0.49
▸ PLG P00747 1/20 0.49
▸ PKM P14618 2/20 0.49
▸ CASP3 P42574 2/20 0.49
▸ CASP1 P29466 1/20 0.49
▸ CASP2 P42575 1/20 0.49
▸ CASP7 P55210 1/20 0.49
▸ CASP8 Q14790 1/20 0.49
▸ CAPN1 P07384 2/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.47
▸ EGLN1 Q9GZT9 1/20 0.47
▸ KDM2A Q9Y2K7 1/20 0.47
▸ F2 P00734 1/20 0.47
▸ HSP90AB1 P08238 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12985194 0.96 FOLH1 (0.63) FOLH1PRSS1PRSS2PRSS3TPSAB1
SCHEMBL8115912 0.83 FOLH1 (0.61) FOLH1PRSS1PRSS2PRSS3TPSAB1
SCHEMBL12767763 0.82 FOLH1 (0.61) FOLH1PRSS1PRSS2PRSS3TPSAB1
SCHEMBL12147642 0.82 FOLH1 (0.61) FOLH1PRSS1PRSS2PRSS3TPSAB1
SCHEMBL12972428 0.80 FOLH1 (0.59) FOLH1PRSS1PRSS2PRSS3TPSAB1
SCHEMBL12743524 0.80 FOLH1 (0.59) FOLH1PRSS1PRSS2PRSS3TPSAB1
SCHEMBL10066226 0.80 CAPN1 (0.58) FOLH1PRSS1PRSS2PRSS3TPSAB1
SCHEMBL14500455 0.79 FOLH1 (0.59) FOLH1PRSS1PRSS2PRSS3TPSAB1
SCHEMBL14524231 0.79 TDP1 (0.54) FOLH1PRSS1PRSS2PRSS3TPSAB1
SCHEMBL14792994 0.78 FOLH1 (0.63) FOLH1PRSS1PRSS2PRSS3TPSAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120165211-A1 Human Antibodies Cross-Reacting With A Bacterial And A Self Antigen From Atherosclerotic Plaques BRACCO IMAGING S.P.A. (IT) 2012-06-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165211-A1 Human Antibodies Cross-Reacting With A Bacterial And A Self Antigen From Atherosclerotic Plaques TAGLN2, TTN, TXLNA FOLH1 3275/4885PRSS1 2410/4885PRSS2 2765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback